SynthesisFrontiers in medicine2025

Characteristics and innovative points of clinical trials of radiotherapy combined with immune checkpoint inhibitors in NSCLC over the past decade.

Mengting Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.